Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 29

1.

Increased PKC activity and altered GSK3β/NMDAR function drive behavior cycling in HINT1-deficient mice: bipolarity or opposing forces.

Garzón-Niño J, Rodríguez-Muñoz M, Cortés-Montero E, Sánchez-Blázquez P.

Sci Rep. 2017 Feb 27;7:43468. doi: 10.1038/srep43468.

2.

A Neural "Tuning Curve" for Multisensory Experience and Cognitive-Perceptual Schizotypy.

Ferri F, Nikolova YS, Perrucci MG, Costantini M, Ferretti A, Gatta V, Huang Z, Edden RAE, Yue Q, D'Aurora M, Sibille E, Stuppia L, Romani GL, Northoff G.

Schizophr Bull. 2017 Feb 7. doi: 10.1093/schbul/sbw174. [Epub ahead of print]

PMID:
28168302
3.

Bipolar Disorder Associated microRNA, miR-1908-5p, Regulates the Expression of Genes Functioning in Neuronal Glutamatergic Synapses.

Kim Y, Zhang Y, Pang K, Kang H, Park H, Lee Y, Lee B, Lee HJ, Kim WK, Geum D, Han K.

Exp Neurobiol. 2016 Dec;25(6):296-306. doi: 10.5607/en.2016.25.6.296. Epub 2016 Oct 28.

4.

Genetic Studies on the Tripartite Glutamate Synapse in the Pathophysiology and Therapeutics of Mood Disorders.

de Sousa RT, Loch AA, Carvalho AF, Brunoni AR, Haddad MR, Henter ID, Zarate CA, Machado-Vieira R.

Neuropsychopharmacology. 2017 Mar;42(4):787-800. doi: 10.1038/npp.2016.149. Epub 2016 Aug 11. Review.

PMID:
27510426
5.

Influence of Genetic Variants of the N-Methyl-D-Aspartate Receptor on Emotion and Social Behavior in Adolescents.

Lee LC, Cho YC, Lin PJ, Yeh TC, Chang CY, Yeh TK.

Neural Plast. 2016;2016:6851592. doi: 10.1155/2016/6851592. Epub 2015 Dec 24.

6.

Circadian Mechanisms Underlying Reward-Related Neurophysiology and Synaptic Plasticity.

Parekh PK, McClung CA.

Front Psychiatry. 2016 Jan 12;6:187. doi: 10.3389/fpsyt.2015.00187. eCollection 2015. Review.

7.

Future Directions for Pharmacotherapies for Treatment-resistant Bipolar Disorder.

Dodd S, Fernandes BS, Dean OM.

Curr Neuropharmacol. 2015;13(5):656-62. Review.

8.

The N-methyl-D-aspartate receptor as a neurobiological intersection between bipolar disorder and alcohol use: a longitudinal mismatch negativity study.

Chitty KM, Lagopoulos J, Kaur M, Hickie IB, Hermens DF.

Int J Neuropsychopharmacol. 2015 Jan 20;18(6). pii: pyu113. doi: 10.1093/ijnp/pyu113.

9.

Neural correlates of rapid antidepressant response to ketamine in bipolar disorder.

Nugent AC, Diazgranados N, Carlson PJ, Ibrahim L, Luckenbaugh DA, Brutsche N, Herscovitch P, Drevets WC, Zarate CA Jr.

Bipolar Disord. 2014 Mar;16(2):119-28. doi: 10.1111/bdi.12118. Epub 2013 Sep 18.

10.

Opposite roles of NMDA receptors in relapsing and primary progressive multiple sclerosis.

Rossi S, Studer V, Moscatelli A, Motta C, Coghe G, Fenu G, Caillier S, Buttari F, Mori F, Barbieri F, Castelli M, De Chiara V, Monteleone F, Mancino R, Bernardi G, Baranzini SE, Marrosu MG, Oksenberg JR, Centonze D.

PLoS One. 2013 Jun 28;8(6):e67357. doi: 10.1371/journal.pone.0067357. Print 2013.

11.

Neurochemical Changes in the Mouse Hippocampus Underlying the Antidepressant Effect of Genetic Deletion of P2X7 Receptors.

Csölle C, Baranyi M, Zsilla G, Kittel A, Gölöncsér F, Illes P, Papp E, Vizi ES, Sperlágh B.

PLoS One. 2013 Jun 21;8(6):e66547. doi: 10.1371/journal.pone.0066547. Print 2013.

12.

ENU-mutagenesis mice with a non-synonymous mutation in Grin1 exhibit abnormal anxiety-like behaviors, impaired fear memory, and decreased acoustic startle response.

Umemori J, Takao K, Koshimizu H, Hattori S, Furuse T, Wakana S, Miyakawa T.

BMC Res Notes. 2013 May 21;6:203. doi: 10.1186/1756-0500-6-203.

13.

Replication of ketamine's antidepressant efficacy in bipolar depression: a randomized controlled add-on trial.

Zarate CA Jr, Brutsche NE, Ibrahim L, Franco-Chaves J, Diazgranados N, Cravchik A, Selter J, Marquardt CA, Liberty V, Luckenbaugh DA.

Biol Psychiatry. 2012 Jun 1;71(11):939-46. doi: 10.1016/j.biopsych.2011.12.010. Epub 2012 Jan 31.

14.

The absence of P2X7 receptors (P2rx7) on non-haematopoietic cells leads to selective alteration in mood-related behaviour with dysregulated gene expression and stress reactivity in mice.

Csölle C, Andó RD, Kittel Á, Gölöncsér F, Baranyi M, Soproni K, Zelena D, Haller J, Németh T, Mócsai A, Sperlágh B.

Int J Neuropsychopharmacol. 2013 Feb;16(1):213-33. doi: 10.1017/S1461145711001933. Epub 2012 Jan 16.

15.

Expression profiling in neuropsychiatric disorders: emphasis on glutamate receptors in bipolar disorder.

Ginsberg SD, Hemby SE, Smiley JF.

Pharmacol Biochem Behav. 2012 Feb;100(4):705-11. doi: 10.1016/j.pbb.2011.09.015. Epub 2011 Oct 8. Review.

16.

Novel glutamatergic agents for major depressive disorder and bipolar disorder.

Machado-Vieira R, Ibrahim L, Henter ID, Zarate CA Jr.

Pharmacol Biochem Behav. 2012 Feb;100(4):678-87. doi: 10.1016/j.pbb.2011.09.010. Epub 2011 Sep 25. Review.

17.

Database of genetic studies of bipolar disorder.

Piletz JE, Zhang X, Ranade R, Liu C.

Psychiatr Genet. 2011 Apr;21(2):57-68. doi: 10.1097/YPG.0b013e328341a346.

18.

Microarray data integration for genome-wide analysis of human tissue-selective gene expression.

Wang L, Srivastava AK, Schwartz CE.

BMC Genomics. 2010 Nov 2;11 Suppl 2:S15. doi: 10.1186/1471-2164-11-S2-S15.

19.

Glutamatergic modulators: the future of treating mood disorders?

Zarate C Jr, Machado-Vieira R, Henter I, Ibrahim L, Diazgranados N, Salvadore G.

Harv Rev Psychiatry. 2010 Sep-Oct;18(5):293-303. doi: 10.3109/10673229.2010.511059. Review.

20.

A randomized add-on trial of an N-methyl-D-aspartate antagonist in treatment-resistant bipolar depression.

Diazgranados N, Ibrahim L, Brutsche NE, Newberg A, Kronstein P, Khalife S, Kammerer WA, Quezado Z, Luckenbaugh DA, Salvadore G, Machado-Vieira R, Manji HK, Zarate CA Jr.

Arch Gen Psychiatry. 2010 Aug;67(8):793-802. doi: 10.1001/archgenpsychiatry.2010.90.

Supplemental Content

Support Center